What is the share price of Indraprastha Medical Corporation Ltd (INDRAMEDCO) today?
The share price of INDRAMEDCO as on 30th September 2026 is ₹348.95. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.What is the return on Indraprastha Medical Corporation Ltd (INDRAMEDCO) share?
The past returns of Indraprastha Medical Corporation Ltd (INDRAMEDCO) share are- Past 1 week: -2.80%
- Past 1 month: -5.18%
- Past 3 months: -10.01%
- Past 6 months: -6.22%
- Past 1 year: -21.49%
- Past 3 years: 108.04%
- Past 5 years: 343.71%
What are the peers or stocks similar to Indraprastha Medical Corporation Ltd (INDRAMEDCO)?
The peers or stocks similar to Indraprastha Medical Corporation Ltd (INDRAMEDCO) include:What is the dividend yield % of Indraprastha Medical Corporation Ltd (INDRAMEDCO) share?
The current dividend yield of Indraprastha Medical Corporation Ltd (INDRAMEDCO) is 1.15.What is the market cap of Indraprastha Medical Corporation Ltd (INDRAMEDCO) share?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Indraprastha Medical Corporation Ltd (INDRAMEDCO) is ₹3198.93 Cr as of 30th September 2026.What is the 52 week high and low of Indraprastha Medical Corporation Ltd (INDRAMEDCO) share?
The 52-week high of Indraprastha Medical Corporation Ltd (INDRAMEDCO) is ₹640.85 and the 52-week low is ₹340.20.What is the PE and PB ratio of Indraprastha Medical Corporation Ltd (INDRAMEDCO) stock?
The P/E (price-to-earnings) ratio of Indraprastha Medical Corporation Ltd (INDRAMEDCO) is 17.42. The P/B (price-to-book) ratio is 4.32.Which sector does Indraprastha Medical Corporation Ltd (INDRAMEDCO) belong to?
Indraprastha Medical Corporation Ltd (INDRAMEDCO) belongs to the Health Care sector & Hospitals & Diagnostic Centres sub-sector.How to buy Indraprastha Medical Corporation Ltd (INDRAMEDCO) shares?
You can directly buy Indraprastha Medical Corporation Ltd (INDRAMEDCO) shares on Tickertape. Simply sign up, connect your demat account and place your order.
Indraprastha Medical Corporation Ltd
INDRAMEDCO Share Price
NSE₹348.951.65% (-5.85)
High
—
—
Low
—
—
Returns
—
—
1D
1W
1M
1Y
5Y
Max
SIP
1D
1W
1M
1Y
5Y
Max
SIP
INDRAMEDCO Stock Scorecard
Performance
AvgPrice return has been average, nothing exciting
Valuation
HighSeems to be overvalued vs the market average
Growth
AvgFinancials growth has been moderate for a few years
Profitability
HighShowing good signs of profitability & efficiency
Entry point
GoodThe stock is underpriced and is not in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
INDRAMEDCO Performance & Key Metrics
INDRAMEDCO Performance & Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| 17.01 | 4.32 | 1.15% |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 45.94 | 5.75 | 0.49% |
100%
Analysts have suggested that investors can buy this stock
from 1 analyst
Price Upside
Earnings Growth
Rev. Growth
INDRAMEDCO Company Profile
Indraprastha Medical Corporation Limited is engaged in healthcare business.
APOLLOHOSP
PE Ratio
60.47
60.47
1Y Return
9.12%
9.12%
Buy Reco %
86.67
86.67
MANIPALHOS
PE Ratio
104.41
104.41
1Y Return
6.30%
6.30%
Buy Reco %
66.67
66.67
MAXHEALTH
PE Ratio
62.74
62.74
1Y Return
17.02%
17.02%
Buy Reco %
83.33
83.33
PE Ratio
156.56
156.56
1Y Return
11.17%
11.17%
Buy Reco %
91.67
91.67
FORTIS
PE Ratio
55.80
55.80
1Y Return
21.12%
21.12%
Buy Reco %
90.00
90.00
INDRAMEDCO Forecast
INDRAMEDCO Forecasts
Price
Revenue
Earnings
INDRAMEDCO Share Price Forecast
INDRAMEDCO Share Price Forecast
2026
Current
₹349.20
Baseline
Forecast for Oct 2027
High
₹—
Median
₹—
Low
₹—
All values in ₹
2026
Current
₹349.20
Baseline
Forecast for Oct 2027
High
₹—
Median
₹—
Low
₹—
All values in ₹
INDRAMEDCO Company Revenue Forecast
INDRAMEDCO Company Revenue Forecast
2026
Current
₹1.51
Baseline
Forecast for Mar 2027
High
₹—
Median
₹—
Low
₹—
All values in ₹ Thousand cr.
2026
Current
₹1.51
Baseline
Forecast for Mar 2027
High
₹—
Median
₹—
Low
₹—
All values in ₹ Thousand cr.
INDRAMEDCO Stock EPS (Earnings Per Share) Forecast
INDRAMEDCO Stock EPS (Earnings Per Share) Forecast
2026
Current
₹20.03
Baseline
Forecast for Mar 2027
High
₹—
Median
₹—
Low
₹—
All values in ₹
2026
Current
₹20.03
Baseline
Forecast for Mar 2027
High
₹—
Median
₹—
Low
₹—
All values in ₹
INDRAMEDCO
INDRAMEDCO
Income
Balance Sheet
Cash Flow
Quarterly Normal View
INDRAMEDCO Income Statement
INDRAMEDCO Income Statement
Quarterly Normal View
| Quarter | mar 2024 | jun 2024 | sep 2024 | dec 2024 | mar 2025 | jun 2025 | sep 2025 | dec 2025 | mar 2026 | jun 2026 | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 319.62 | 352.98 | 355.87 | 330.06 | 340.10 | 371.96 | 388.40 | 378.76 | 372.14 | 414.57 | ||||||||||
Operating & Other expenses | 266.29 | 280.74 | 286.18 | 272.74 | 272.43 | 291.91 | 309.72 | 309.66 | 304.30 | 326.34 | ||||||||||
EBITDA | 53.33 | 72.24 | 69.69 | 57.32 | 67.67 | 80.05 | 78.68 | 69.10 | 67.84 | 88.23 | ||||||||||
| Depreciation/Amortization | 10.21 | 11.04 | 11.17 | 11.21 | 10.91 | 10.18 | 10.86 | 11.25 | 11.34 | 11.76 | ||||||||||
| PBIT | 43.12 | 61.20 | 58.52 | 46.11 | 56.76 | 69.87 | 67.82 | 57.85 | 56.50 | 76.47 | ||||||||||
| Interest & Other Items | 1.56 | 1.61 | 1.59 | 1.58 | 1.49 | 1.56 | 1.51 | 1.46 | 1.49 | 1.65 | ||||||||||
| PBT | 41.56 | 59.59 | 56.93 | 44.53 | 55.27 | 68.31 | 66.31 | 56.39 | 55.01 | 74.82 | ||||||||||
| Taxes & Other Items | 10.39 | 14.82 | 14.53 | 11.72 | 14.26 | 16.85 | 16.85 | 15.39 | 13.31 | 18.97 | ||||||||||
| Net Income | 31.17 | 44.77 | 42.40 | 32.81 | 41.01 | 51.46 | 49.46 | 41.00 | 41.70 | 55.85 | ||||||||||
| EPS | 3.40 | 4.88 | 4.63 | 3.58 | 4.47 | 5.61 | 5.40 | 4.47 | 4.55 | 6.09 |
INDRAMEDCO Company Updates
INDRAMEDCO Stock Peers
INDRAMEDCO Past Performance & Peer Comparison
INDRAMEDCO Past Performance & Peer Comparison
Comparing 3 stocks from
Health CareHospitals & Diagnostic Centres
Compare valuation on Screener
Health CareHospitals & Diagnostic Centres
Valuation
Technical
Forecast
Compare valuation on Screener| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| Indraprastha Medical Corporation Ltd | 17.42 | 4.32 | 1.15% |
| Apollo Hospitals Enterprise Limited | 60.47 | 11.76 | 0.24% |
| Manipal Health Enterprises Limited | 104.41 | 10.59 | — |
| Max Healthcare Institute Limited | 62.74 | 8.42 | 0.22% |
INDRAMEDCO Stock Price Comparison
Compare INDRAMEDCO with any stock or ETFCompare INDRAMEDCO with any stock or ETF
INDRAMEDCO
INDRAMEDCO Holdings
INDRAMEDCO Shareholdings
INDRAMEDCO Promoter Holdings Trend
INDRAMEDCO Promoter Holdings Trend
Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook
In last 6 months, promoter holding in the company has almost stayed constant
Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better
Pledged promoter holdings is insignificant
INDRAMEDCO Institutional Holdings Trend
INDRAMEDCO Institutional Holdings Trend
Increased Total Retail Holding
Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.
In last 3 months, retail holding in the company has increased by 1.10%
Foreign Institutional Holding
Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock
In last 3 months, foreign institutional holding of the company has almost stayed constant
INDRAMEDCO Shareholding Pattern
INDRAMEDCO Shareholding Pattern
INDRAMEDCO Shareholding History
INDRAMEDCO Shareholding History
Foreign Institutions
Mutual Funds Invested in INDRAMEDCO
Mutual Funds Invested in INDRAMEDCO
No mutual funds holding trends are available
Top 2 Mutual Funds holding Indraprastha Medical Corporation Ltd
| Funds (Top 2) | The rupee value of the stock held by the fund divided by the stock’s market cap Market-cap held | Percentage of the fund’s portfolio invested in the stock Weight | Change in the portfolio weight of the stock over the last 3 months 3M holding change | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months Portfolio rank(3M change) |
|---|---|---|---|---|
The rupee value of the stock held by the fund divided by the stock’s market cap 0.0006% | Percentage of the fund’s portfolio invested in the stock 0.10% | Change in the portfolio weight of the stock over the last 3 months -0.01% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 81/130 (-4) | |
The rupee value of the stock held by the fund divided by the stock’s market cap 0.0001% | Percentage of the fund’s portfolio invested in the stock 0.01% | Change in the portfolio weight of the stock over the last 3 months -0.00% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 846/1009 (-13) |
Compare 3-month MF holding change on Screener
Hmm, looks like there hasn't been any net deal activity in the last 6 monthssmallcases containing INDRAMEDCO stock
smallcases containing INDRAMEDCO stock
Looks like this stock is not in any smallcase yet.
INDRAMEDCO Events
INDRAMEDCO Events
INDRAMEDCO Dividend Trend
No Trend In Dividends
Dividends are the portion of earnings that a company distributes to all its shareholders every year
INDRAMEDCO has shown inconsistent dividend trend over the last 5 years
Dividend Yield
Dividend return is one of the most important things to be considered while investing for long term. It is the additional return on top of what investors earn through price appreciation
Current dividend yield is 1.13%. An investment of ₹1,000 in the stock is expected to generate dividend of ₹11.27 every year
Dividends
Corp. Actions
Announcements
Legal Orders
Dividends
INDRAMEDCO Dividend Trend
No Trend In Dividends
Dividends are the portion of earnings that a company distributes to all its shareholders every year
INDRAMEDCO has shown inconsistent dividend trend over the last 5 years
Dividend Yield
Dividend return is one of the most important things to be considered while investing for long term. It is the additional return on top of what investors earn through price appreciation
Current dividend yield is 1.13%. An investment of ₹1,000 in the stock is expected to generate dividend of ₹11.27 every year
INDRAMEDCO Upcoming Dividends
INDRAMEDCO Upcoming Dividends
No upcoming dividends are available
INDRAMEDCO Past Dividends
INDRAMEDCO Past Dividends
Cash Dividend
Ex DateEx DateSep 18, 2026
Final
Final | Div/Share: ₹4.00
Dividend/Share
₹4.00
Ex DateEx Date
Sep 18, 2026
Cash Dividend
Ex DateEx DateSep 18, 2025
Final
Final | Div/Share: ₹4.50
Dividend/Share
₹4.50
Ex DateEx Date
Sep 18, 2025
Cash Dividend
Ex DateEx DateSep 13, 2024
Final
Final | Div/Share: ₹4.50
Dividend/Share
₹4.50
Ex DateEx Date
Sep 13, 2024
Cash Dividend
Ex DateEx DateSep 15, 2023
Final
Final | Div/Share: ₹3.00
Dividend/Share
₹3.00
Ex DateEx Date
Sep 15, 2023
Cash Dividend
Ex DateEx DateSep 15, 2022
Final
Final | Div/Share: ₹2.50
Dividend/Share
₹2.50
Ex DateEx Date
Sep 15, 2022
INDRAMEDCO Stock News & Opinions
INDRAMEDCO Stock News & Opinions
Articles & Videos
Corporate
Corporate
Indraprastha Apollo Hospitals restricts trading for insiders ahead of Q3 2026 resultsIndraprastha Medical Corporation Limited, which operates as Indraprastha Apollo Hospitals, will close its trading window for designated persons, including promoters, directors, and key managerial personnel, from October 1, 2026, until 48 hours after the company declares its unaudited financial results for the quarter ending September 30, 2026; during this period, the Permanent Account Numbers of designated persons and their connected persons will be frozen for trading in the company's securities.
1 week agoCapital Market - Live
Corporate
Corporate
Indraprastha Medical Corporation to announce Quarterly ResultIndraprastha Medical Corporation will hold a meeting of the Board of Directors of the Company on 6 August 2026.
2 months agoCapital Market - Live
Corporate
Corporate
Indraprastha Medical Corporation receives reaffirmation in credit ratingsIndraprastha Medical Corporation announced that ICRA has re-affirmed its rating on the long term bank facility and instrument of the company at '[ICRA]AA(Stable)' and the short term rating at [ICRA]A1+'.
4 months agoCapital Market - Live
Corporate
Corporate
Board of Indraprastha Medical Corporation recommends final dividendIndraprastha Medical Corporation announced that the Board of Directors of the Company at its meeting held on 12 May 2026, inter alia, have recommended the final dividend of Rs 4 per equity Share (i.e. 40%) , subject to the approval of the shareholders.
4 months agoCapital Market - Live
Earnings
Earnings
Indraprastha Medical Corporation standalone net profit rises 1.68% in the March 2026 quarterNet profit of Indraprastha Medical Corporation rose 1.68% to Rs 41.70 crore in the quarter ended March 2026 as against Rs 41.01 crore during the previous quarter ended March 2025. Sales rose 9.31% to Rs 364.81 crore in the quarter ended March 2026 as against Rs 333.75 crore during the previous quarter ended March 2025. For the full year,net profit rose 14.06% to Rs 183.62 crore in the year ended March 2026 as against Rs 160.99 crore during the previous year ended March 2025. Sales rose 9.30% to Rs 1482.51 crore in the year ended March 2026 as against Rs 1356.36 crore during the previous year ended March 2025. ParticularsQuarter EndedYear EndedMar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var. Sales364.81333.75 9 1482.511356.36 9 OPM %16.5918.37 -18.0018.01 - PBDT66.3566.18 0 289.65260.65 11 PBT55.0155.27 0 246.02216.32 14 NP41.7041.01 2 183.62160.99 14 Powered by Capital Market - Live
4 months agoCapital Market - Live
Corporate
Corporate
Indraprastha Medical Corporation to discuss resultsIndraprastha Medical Corporation will hold a meeting of the Board of Directors of the Company on 12 May 2026.
4 months agoCapital Market - Live
Earnings
Earnings
Indraprastha Medical Corporation standalone net profit rises 24.96% in the December 2025 quarterNet profit of Indraprastha Medical Corporation rose 24.96% to Rs 41.00 crore in the quarter ended December 2025 as against Rs 32.81 crore during the previous quarter ended December 2024. Sales rose 14.37% to Rs 371.61 crore in the quarter ended December 2025 as against Rs 324.93 crore during the previous quarter ended December 2024. ParticularsQuarter EndedDec. 2025Dec. 2024% Var. Sales371.61324.93 14 OPM %16.6716.06 - PBDT67.6455.74 21 PBT56.3944.53 27 NP41.0032.81 25 Powered by Capital Market - Live
7 months agoCapital Market - Live
Corporate
Corporate
Indraprastha Medical Corporation to conduct board meetingIndraprastha Medical Corporation will hold a meeting of the Board of Directors of the Company on 3 February 2026.Powered by Capital Market - Live
8 months agoCapital Market - Live
Earnings
Earnings
Indraprastha Medical Corporation standalone net profit rises 16.65% in the September 2025 quarterNet profit of Indraprastha Medical Corporation rose 16.65% to Rs 49.46 crore in the quarter ended September 2025 as against Rs 42.40 crore during the previous quarter ended September 2024. Sales rose 8.92% to Rs 381.03 crore in the quarter ended September 2025 as against Rs 349.82 crore during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var. Sales381.03349.82 9 OPM %18.7218.19 - PBDT77.1768.10 13 PBT66.3156.93 16 NP49.4642.40 17 Powered by Capital Market - Live
10 months agoCapital Market - Live
Corporate
Corporate
Indraprastha Medical Corporation to discuss resultsIndraprastha Medical Corporation will hold a meeting of the Board of Directors of the Company on 1 November 2025.Powered by Capital Market - Live
11 months agoCapital Market - Live
Over the last 5 years, revenue has grown at a yearly rate of 19.74%, vs industry avg of 18.03%
Over the last 5 years, market share increased from 1.4% to 1.46%
Over the last 5 years, net income has grown at a yearly rate of 139.5%, vs industry avg of 62.59%